| PERIOD ENDING | 24-Apr-09 | 25-Apr-08 | 27-Apr-07 | | Total Revenue | 3,406,393 | 3,303,167 | 2,804,282 | | Cost of Revenue | 1,416,478 | 1,289,791 | 1,099,782 | | | Gross Profit | 1,989,915 | 2,013,376 | 1,704,500 | | | Operating Expenses | | Research Development | 498,495 | 452,205 | 385,357 | | Selling General and Administrative | 1,389,839 | 1,247,124 | 1,043,314 | | Non Recurring | 54,406 | 447 | (25,413) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 47,175 | 313,600 | 301,242 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 24,519 | 77,089 | 70,128 | | Earnings Before Interest And Taxes | 71,694 | 390,689 | 371,370 | | Interest Expense | 26,865 | 7,990 | 11,642 | | Income Before Tax | 44,829 | 382,699 | 359,728 | | Income Tax Expense | (41,716) | 72,961 | 61,993 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 86,545 | 309,738 | 297,735 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 86,545 | 309,738 | 297,735 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $86,545 | $309,738 | $297,735 |
|
1.48% Nasdaq 
Income Statement
